Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Percutaneous hyaluronidase vs PLDD vs ozone injection for lumbar radiculopathy
IRCT20130523013442N36Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hyaluronidase and medical ozonated water in lumbosacral radiculopathy and Herniated Lumbar Disk (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
hyaluronidasemedical ozonated water
03
Conditions
lumbosacral radiculopathyHerniated Lumbar Disk
Beyond the preview
Go deeper on IRCT20130523013442N36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130523013442N36.